Crossmark

The accessibility of data on environmental risk assessment of pharmaceuticals: Is the marketing authorisation procedure in conflict with the international right of access to environmental information?

Crossref DOI link: https://doi.org/10.1186/s12302-019-0256-3

Published Online: 2019-09-25

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Oelkers, Kim http://orcid.org/0000-0001-5814-315X
Floeter, Carolin
License Information

Text and Data Mining valid from 2019-09-25

Version of Record valid from 2019-09-25
More Information

Article History

Received: 15 July 2019

Accepted: 3 September 2019

First Online: 25 September 2019

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below